A review of glucagon‐like peptide‐1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus
David R. Owens; Louis Monnier; Markolf Hanefeld
Author Information: Diabetes Research Group, Institute of Life Sciences College of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.